Further clarification of the molecular relationship between ERβ and p53 may contribute to clarification of the mechanisms of endometrioid carcinoma progression and yield more useful tools to predict the risk of progression in the future. This evidence concerns the gene ESR2 and endometrioid adenocarcinoma.